Bruton's tyrosine kinase (BTK) is involved in B-cell development. Mutation of BTK results in X-linked agammaglobulinemia (XLA). BTK is expressed in most haemopoietic lineages except mature T cells and plasma cells. We identified six novel and two known mutations of BTK in 11 Chinese XLA patients from 8 families. Family 1 had a novel point mutation at the start codon (135G-->T) in exon 2. Family 2 had known mutation of single A insertion in a stretch of 7 A residues (341-347insA) recognized as mutation hotspot in exon 3. Family 3 had a novel point mutation in exon 11 (1074A-->G) which led to aberrant splicing. Family 4 had known mutation in exon 19 (2053C-->T) in CpG mutation hotspot. The novel mutation of family 5 was an A deleted in a run of three As (1017-1019delA) in exon 10. In family 6, exons 2 and 3 were lost in BTK mRNA, a novel deletion. Family 7 had a novel substitution in exon 2 (227T-->C) which led to change of a conserved leucine to serine. Family 8 had a novel point mutation at beginning of intron 14 (IVS14+ 6 T-->G) resulting in aberrant splicing. Hum Mutat 15:385, 2000. Copyright 2000 Wiley-Liss, Inc.
CITATION STYLE
Yip, K. L., Chan, S. Y., Ip, W. K., & Lau, Y. L. (2000). Bruton’s tyrosine kinase mutations in 8 Chinese families with X-linked agammaglobulinemia. Human Mutation, 15(4), 385. https://doi.org/10.1002/(SICI)1098-1004(200004)15:4<385::AID-HUMU21>3.0.CO;2-D
Mendeley helps you to discover research relevant for your work.